Skip to main content
editorial
. 2021 Jun 15;6(4):100174. doi: 10.1016/j.esmoop.2021.100174

Table 2.

The objectives of EURACAN-ERN for rare adult solid cancers

  • •

    To increase access to accurate pathological and molecular diagnosis of rare cancers.

  • •

    To improve access to optimal standard treatments as well as innovation across all EU member states.

  • •

    To develop training programmes for medical teams in all countries to increase and harmonise the quality of care for rare cancers.

  • •

    To integrate patient advocacy groups for the construction and dissemination of the work of the network as well as for educational tools.

  • •

    To implement ‘roadmaps’ for referral and self-referral of patients to expert centres.

  • •

    To develop and continuously review Clinical Practice Guidelines (CPGs).

  • •

    To interact with key national and international actors/networks involved in cancer care and research and beyond, with other rare diseases stakeholders.

ERN, European Reference Network; EU, European Union; EURACAN, the European Reference Network for rare adult solid cancers.